Hancock Whitney’s Eagle Pharmaceuticals, Inc. EGRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q2 | – | Sell |
-5,433
| Closed | -$227K | – | 861 |
|
|
2021
Q1 | $227K | Buy |
+5,433
| New | +$227K | 0.01% | 713 |
|
|
2020
Q4 | – | Sell |
-5,515
| Closed | -$234K | – | 856 |
|
|
2020
Q3 | $234K | Buy |
5,515
+209
| +4% | +$8.87K | 0.01% | 684 |
|
|
2020
Q2 | $255K | Sell |
5,306
-2,130
| -29% | -$102K | 0.01% | 659 |
|
|
2020
Q1 | $342K | Sell |
7,436
-4,620
| -38% | -$212K | 0.01% | 598 |
|
|
2019
Q4 | $724K | Buy |
12,056
+2,976
| +33% | +$179K | 0.02% | 502 |
|
|
2019
Q3 | $514K | Sell |
9,080
-601
| -6% | -$34K | 0.02% | 585 |
|
|
2019
Q2 | $539K | Buy |
+9,681
| New | +$539K | 0.02% | 605 |
|